Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 3,262

Document Document Title
WO/2014/017042A1
[Problem] To manufacture, in a stable manner, an organic photoelectric conversion element having an equivalent performance, and an imaging element provided with the same. [Solution] A film-forming organic material (60) used for dry film-...  
WO/2014/005546A1
The present invention relates to a preparation method of tapentadol hydrochloride and compounds for preparation of the tapentadol hydrochloride. The preparation method comprises steps using a compound in a formula V or a hydrochloride th...  
WO/2013/170859A2
The present invention provides polymeric photoinitiators being co-polymers of photoinitiator monomers and at least one further monomer, as well as the photoinitiator monomers being intermediates in the preparation of such polymeric photo...  
WO/2013/168002A1
The invention relates to the compounds of formula (I) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amoun...  
WO/2013/161816A1
The present invention provides a compound represented by general formula (I) [wherein each symbol is as defined in the description], which has an excellent peripheral blood lymphocyte-reducing activity and is useful for the treatment or ...  
WO/2013/121997A1
The purpose of the present invention is to provide: a method for obtaining hydrogen or deuterium with high efficiency or hydrogenating or deuterating an organic compound; a device for use in the method; and others. Provided are: a method...  
WO/2013/120876A1
The present invention pertains to novel enaminoketones containing a CF3O-group, novel pyrazole-derivatives containing a CF3O group as well as to a novel process for their preparation comprising aminoformylation of CF30-ketones and cycliz...  
WO/2013/103146A1
The purpose of the invention is to provide a novel nucleic acid molecule that can be produced easily and efficiently and makes it possible to suppress the expression of a gene. A single-stranded nucleic acid molecule containing an expres...  
WO/2013/095301A1
Present invention relates to a method of preparing a chiral α- or β-substituted ketone from the corresponding β- or γ-substituted aldehyde, wherein the ketone has formula (I), (III) or (V), and the corresponding aldehyde has formula ...  
WO/2013/087770A1
The present invention relates to quinone direct dyes of formula (I) below, organic or mineral acid or base salts thereof,tautomeric forms, optical isomers or geometrical isomers thereof and/or solvates thereof: and also to the use thereo...  
WO/2013/049280A3
The disclosure relates to compounds, pharmaceutical compositions, and methods of treating or preventing disease. In certain embodiments, the disclosure relates to methods of treating an infection or cancer comprising administering a phar...  
WO/2013/077720A1
Methods for producing methadone and its resolution to produce (R)-6-dimethylamino-4,4-diphenylheptan-3-one ((R)- methadone). Such methods producing first the precursor compound 4-(dimethylamino)-2,2-diphenylpentanitrile. Oxidation of 4-(...  
WO/2013/067547A1
The present invention discloses utilization of the anthracene-9,10-dione dioxime compound: 2-((3R,5S)-3,5-dimethylpiperdin-1ylsulfonyl)-7-((3S,5R)-3,5- dimethylpiperidin-1-ylsulfonyl)anthracene-9,10-dione dioxime for the treatment of can...  
WO/2013/061724A1
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/056229A1
The disclosure provides pharmaceutical preparations containing (2R,6R)-hydroxynorketamine, or (R)- or (S)-dehydronorketamine, or other stereoisomeric dehydro or hydroxylated ketamine metabolite. (2R,6R)-hydroxynorketamine The disclosure ...  
WO/2012/157983A3
The present invention relates to an amine compound, a method for preparing same, and a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device, having same. A liquid crystal alignment agent ha...  
WO/2013/026942A1
The invention provides combretastatin A-4 like compounds that are modified to have enhanced tubulin binding activity and in some embodiments the ability to promote accumulation in the vasculature undergoing angiogenesis (homing activity)...  
WO/2012/157982A3
The present invention relates to an amine compound, a method for preparing same, and a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device, having same. A liquid crystal alignment agent ha...  
WO/2012/165648A1
The present invention provides a compound having an excellent efficacy for controlling weeds. A cyclohexanone compound of the formula (I): wherein m is an integer of 1, 2 or 3; n is an integer of any one of 1 to 5; X represents CH2, O, S...  
WO/2012/154904A1
Disclosed are compounds that inhibit RNase H activity of retroviruses, for example, a compound of formula (I) wherein R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts, solvates, stereoisomers, and prod...  
WO/2012/088268A3
Method for identifying a modulator of Sirt6, PfSir2a, or Sirt7 deacylase activity, wherein a fatty-acylated substrate containing an acyl-lysine moiety and an indicator moiety is contacted with Sirt6, PfSir2a, or Sirt7 in the presence of ...  
WO/2012/136121A1
An amino phenylpropanoid compound, or a geometric isomer thereof, or a pharmaceutically acceptable salt or hydrate thereof as represented by Formula I, a preparation method therefor, and a pharmaceutical composition containing the compou...  
WO/2012/137741A1
A method for purifying an organic material, which can sublimate and purify an organic material having a high sublimation temperature and high heat resistance within a short time with high purity and high yield. The method comprises: redu...  
WO/2012/084830A1
Novel compositions are described, comprising (1) β-ketocarbonyl quat compounds which contain one or more β-ketocarbonyl groups of the general formula (I): R-CH2- (C=O) -CHR- (C=O) - and one or more quaternary ammonium groups, where R m...  
WO/2012/088268A2
Method for identifying a modulator of Sirt6, PfSir2a, or Sirt7 deacylase activity, wherein a fatty-acylated substrate containing an acyl-lysine moiety and an indicator moiety is contacted with Sirt6, PfSir2a, or Sirt7 in the presence of ...  
WO/2011/156003A3
Novel peptide/peptoid oligomers are disclosed that have a formula represented by the following formula la or lb: The peptide/peptoid oligomers demonstrate the ability to inhibit fibnllization and oligomerization of Αβ and may be prepar...  
WO/2011/151789A3
This invention relates to B-ring aminoalkyl substituted chalcones and analogues thereof. It also relates to processes for the synthesis of such compounds and to the use of such compounds as medicaments, in particular but not exclusively ...  
WO/2012/062041A1
Disclosed are aromatic ketone compounds with para- or meso-substituted multifunctional groups as represented by the general formulae I-III, preparation methods thereof, and free-radical polymerization photoinitiators comprising the compo...  
WO/2012/031466A1
Disclosed are 2-(p-octylphenylethyl)-2-amino propanediol derivatives of formula (I) and uses thereof wherein, R1, R2, R3 is selected independently from H or acyl; R4 is selected from methylene, carbonyl, (II) or (III); R5 is trans-4-meth...  
WO/2012/032990A1
To provide a compound which contributes to providing a photoelectric conversion element that exhibits high photoelectric conversion efficiency, low dark current, and rapid response, and which does not decompose during vapor deposition. T...  
WO/2012/023546A1
The purpose of the present invention is to provide a process by which hydrogen or heavy hydrogens can be easily produced without using large-scale equipment and a process by which hydrogenation (protiation, deuteration or tritiation) can...  
WO/2011/082770A3
The invention relates to novel compounds of formula (I) having Rf terminal groups, the use thereof as surface-active substances and methods for producing said compounds.  
WO/2012/001571A1
The object of the present invention is a new process for the synthesis of tapentadol, both as free base and in hydrochloride form, which comprises the step of alkylation of the ketone (VII) to yield the compound (VIII), as reported in Di...  
WO/2012/000846A1
The present invention relates to the use of a composition comprising specific a-amino- ketones, H2O2, a H2O2 precursor or a peracid and optionally an activator as a bleaching mixture for textile materials or dishes either manually or in ...  
WO/2011/156003A2
Novel peptide/peptoid oligomers are disclosed that have a formula represented by the following formula la or lb: The peptide/peptoid oligomers demonstrate the ability to inhibit fibnllization and oligomerization of Αβ and may be prepar...  
WO/2011/119456A1
Nitrogen-containing fluorochemical ketones are provided that can be useful in apparatuses that includes a device and a mechanism for transferring heat. The provided fluorochemical ketones are stable at temperatures above 170°C, are envi...  
WO/2011/107705A1
The present invention relates to ketobenzofuran derivatives of the general formula (D) shown below, as well as to a method for synthesising same by coupling a quinonimine and an enaminone by a Nenitzescu reaction and to the intermediates...  
WO/2011/043549A3
The present invention relates to a fatty acid amino ester and to a skin-whitening composition comprising same. It is an aim of the present invention to provide a fatty acid amino ester which is not harmful to the human body and which has...  
WO/2011/050270A3
The present invention relates to novel macrocyclic compounds and salts thereof that bind to and/or are inhibitors of serine protease enzymes. The present invention also relates to intermediates of these compounds, pharmaceutical composit...  
WO/2011/014025A3
The present invention relates to a derivative of hydroxy-cinnamic acid in which a peptide has been bonded, a production method for the same, and a cosmetic composition comprising the same. More specifically, the present invention concern...  
WO/2009/019616A3
The present invention relates to the preparation of various benzo[α]fluorenes The benzo[α]fluorene moiety appears in a variety of natural products, some of which have been shown to exhibit anticancer and antibacterial effects Methods o...  
WO/2011/043549A2
The present invention relates to a fatty acid amino ester and to a skin-whitening composition comprising same. It is an aim of the present invention to provide a fatty acid amino ester which is not harmful to the human body and which has...  
WO/2010/132879A3
Degradable polymers were synthesized that self-assemble with DNA to form particles that are effective for gene delivery. Small changes to polymer synthesis conditions, particle formulation conditions, and polymer structure provides signi...  
WO/2011/035875A1
3-Amino-2-nitro-substituted benzoyl derivatives of the general formula (I) are described. In this formula (I), X, R1, R2, R3, R4, R5, R6, R7 and R8 stand for radicals such as hydrogen, organic radicals such as alkyl, and other radicals s...  
WO/2011/026314A1
The preparation method of tapentadol and intermediates thereof are provided. The intermediates are the compounds represented by formula (II), their enantiomorphs, diastereomers, recemes, salts or the mixture thereof.  
WO/2011/021397A1
Provided are 4-modified colchicine compounds and medicines using the same. Specifically provided are colchicine derivatives represented by general formula (1), salts thereof, and solvates of the same. In general formula (1), R1 is a halo...  
WO/2011/014025A2
The present invention relates to a derivative of hydroxy-cinnamic acid in which a peptide has been bonded, a production method for the same, and a cosmetic composition comprising the same. More specifically, the present invention concern...  
WO/2011/006064A1
Disclosed are processes for the use of bis-ketoiminate metal precursors for the deposition of metal-containing films via conventional CVD, low pressure chemical vapor deposition (LPCVD), plasma enhanced chemical vapor depositions (PECVD)...  
WO/2011/003193A1
The present disclosure includes compounds of Formula I: wherein R1-R3, Ar, and n are as defined herein, and methods for the quantification of carboxylic acids in samples, specifically biological samples, using the compounds of Formula I....  
WO/2010/144959A1
The present invention relates to analogues of anti-fibrotic agents having the formula (I) with the substituents as described within the specification. The present invention also relates to methods for their preparation.  

Matches 101 - 150 out of 3,262